Lisata Therapeutics Inc (LSTA) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Lisata Therapeutics Inc   (NASDAQ: LSTA)


Lisata Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lisata Therapeutics Inc's ROI in the second quarter of 2026?
Lisata Therapeutics Inc recorded a cumulative net loss of $-15 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -117.24%.

Within the Healthcare sector 643 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3348 to 4067.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -53.77 % -50.12 % -46.21 % -43.33 % -40.41 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 8 10 14 17 21
Return On Investment (TTM) -117.24 % -104.75 % -86.31 % -79.67 % -70.15 %
LSTA's Overall Ranking # 4067 # 3348 # 2918 # 3670 # 3501
Seq. Investment Change TTM -20.1 % -18.77 % -16.07 % -15.12 % -13.79 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -15 -16 -17 -18 -19

LSTA Company Profile >> Back to LSTA Roi Comparisons >> See Annual LSTA Return On Investment



Return On Investment LSTA's Ranking
Within: No.
Industry # 287
Sector # 644
Overall # 4067

Return On Investment Statistics
High Average Low
50.21 %
-54.96 %
-164.61 %
(Mar 31 2018)   (Sep 30 2016)







Financial Statements
Lisata Therapeutics Inc's II. Quarter Investments $ 8 Millions LSTA's Balance sheet
Lisata Therapeutics Inc's II. Quarter Income $ -3 Millions Quarterly LSTA's Income Statement
LSTA's Income by Division See LSTA's Income by Division


LSTA Annual Return On Investment (Dec 31 2025)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 14 48 66 92 32
Y / Y Investment Growth -69.87 % -27.93 % -28.01 % 186.06 % 54.16 %
Net Income in Millions -17 -21 -54 -27 -8
Y / Y Net Income Growth - - - - -
Annual Return On Investment -115.03 % -43.55 % -81.67 % -29.78 % -25.25 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LSTA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LSTA's Competitors
Subscribers only: Roi for Lisata Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for LSTA's Customers

Other Ratios
LSTA's Roa LSTA's Inventory Turnover Ratio LSTA's Growth Rates LSTA's Dividend Statistics
LSTA's Profitability Ratios LSTA's Asset Turnover Ratio LSTA's Dividend Growth
LSTA's Roe LSTA's Valuation Ratios LSTA's Financial Strength Ratios LSTA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T13:54:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.